New Funding Secured To Support Clinical GMP Manufacturing Expansion at Rise Therapeutics
UF Startup Rise Therapeutics announced that it has received funding from the National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) at the National Institute of Health (NIH).
Frozen Food Express Partners With Optym for Pickup and Delivery Route Optimization
UF Startup Optym, the leader in transportation network optimization, announced that Frozen Food Express has begun the rollout of Optym's route optimization solution RouteMax across the FFE network.
RTI Surgical Announces Agreement To Acquire Collagen Solutions
UF Startup RTI Surgical announced that it has entered into an agreement to acquire Collagen Solutions, a premier global supplier of engineered medical-grade collagen and xenograft tissue with applications in cardiac, sports medicine and orthopedics.
LightPath Technologies Awarded Phase 2 Funding in U.S. Defense Department Partnership To Qualify Additional Germanium Substitutes
UF Startup LightPath Technologies announced Strategic Materials has awarded Phase 2 funding to support the qualification of additional LightPath Black Diamond chalcogenide glasses as substitute to germanium.
LightPath Technologies Secures $3.5 Million Follow-On Order To Supply Infrared Optics for F-35 Combat Aircraft Program
UF Startup LightPath Technologies announced a $3.5 million follow-on order to provide advanced infrared optics for the F-35 combat aircraft program.
Cannabix Technologies and Omega Laboratories Inc. Advance Marijuana Breathalyzer Technology – Dr. Bruce Goldberger To Present at Society of Forensic Toxicologists Conference
UF Startup Cannabix Technologies Inc. reports that it will be presenting the Company’s marijuana breathalyzer system at the Society of Forensic Toxicologists (SOFT) conference in St. Louis.
First Patient Enrolled in Phase I Program in STK11 Mutant Non-Small Cell Lung Cancer at Moffitt Cancer Center
Panbela Therapeutics, Inc., formerly Sun Biopharma, a UF startup, announced the first patient enrolled in a Phase I dose-escalation study to evaluate CPP-1X-S (eflornithine sachets) in STK11 mutant non-small cell lung cancer (NSCLC).
Kriya Highlights Positive Preclinical Data for KRIYA-586, a Gene Therapy Product Candidate for Thyroid Eye Disease (TED), at ESOPRS Annual Meeting
UF Startup Kriya Therapeutics, a biopharmaceutical company developing gene therapies, announced preclinical data from its gene therapy program for thyroid eye disease (TED).
Axogen Completes Submission of Biologics License Application to U.S. Food and Drug Administration for Avance Nerve Graft®
UF startup Axogen, Inc., a global leader in developing and marketing innovative surgical solutions for peripheral nerve injuries, announced that it has... Read More
Atsena Therapeutics Receives Rare Pediatric Disease Designation From the U.S. FDA for ATSN-201 Gene Therapy To Treat X-Linked Retinoschisis
UF startup Atsena Therapeutics, a clinical-stage gene therapy company focused on bringing the life-changing power of genetic medicine to reverse or prevent blindness, announced that the U.S. Food and Drug Administration (FDA) has granted Rare Pediatric Disease designation (RPD) for ATSN-201 for the treatment of X-linked retinoschisis (XLRS).
